A pan-cancer landscape of IGF2BPs and their association with prognosis, stemness and tumor immune microenvironment.

Shao, Wei; Zhao, Hui; Zhang, Shoudu; Ding, Qian; Guo, Yugang; Hou, Kaiqi; Kan, Yunchao; Deng, Fan; Xu, Qian

Shao, Wei; Zhao, Hui; Zhang, Shoudu; Ding, Qian; Guo, Yugang; Hou, Kaiqi; Kan, Yunchao; Deng, Fan; Xu, Qian.

Afiliación

Shao W; Henan Provincial Engineering Laboratory of Insects Bio-reactor, Nanyang Normal University, Nanyang, Henan, China.
Zhao H; The Department of Science and Technology, Zhengzhou Revogene Ltd, Zhengzhou, Henan, China.
Zhang S; Henan Provincial Engineering Laboratory of Insects Bio-reactor, Nanyang Normal University, Nanyang, Henan, China.
Ding Q; Henan Provincial Engineering Laboratory of Insects Bio-reactor, Nanyang Normal University, Nanyang, Henan, China.
Guo Y; Henan Provincial Engineering Laboratory of Insects Bio-reactor, Nanyang Normal University, Nanyang, Henan, China.
Hou K; Henan Provincial Engineering Laboratory of Insects Bio-reactor, Nanyang Normal University, Nanyang, Henan, China.
Kan Y; Henan Provincial Engineering Laboratory of Insects Bio-reactor, Nanyang Normal University, Nanyang, Henan, China.
Deng F; Department of Cell Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, Guangdong, China.
Xu Q; Henan Provincial Engineering Laboratory of Insects Bio-reactor, Nanyang Normal University, Nanyang, Henan, China.

Front Oncol ; 12: 1049183, 2022.

Article en En | MEDLINE | ID: mdl-36686749

Palabras clave

glioma stem cells; insulin-like growth factor 2(IGF2) messenger RNA; pan-cancer; prognosis signature; tumor microenvironment

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google